Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial.

Maria Letizia Giancola Andrea FontanaConcetta PanebiancoAntonio MazzarelliAlessia BeccacecePatrizia De MarcoGiovanna CocomazziChiara De GiuliGermana GrassiCarla Fontana Giorgio Maria Baldini Viviana ContuMassimiliano CopettiFrancesco Perri Emanuele Nicastri Valerio Pazienza

Published in: Microorganisms (2024)

Our data suggest that modulating the gut microbiota in acute disease through administration of a specific symbiotic formula could be a useful strategy in the frame of SARS-CoV-2 infections.

Keyphrases

liver failure
sars cov
respiratory failure
drug induced
aortic dissection
hepatitis b virus
placebo controlled
squamous cell carcinoma
clinical trial
mechanical ventilation
preterm infants
acute respiratory distress syndrome
phase ii study
smoking cessation